C4 Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| LYNX1 CAPITAL MANAGEMENT LP | 11/13/2025 | 7.10 M | $15.76 M | 0.00% | 10.00% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 11/14/2025 | 7.05 M | $15.66 M | 1.07% | 9.93% |
| ORBIMED ADVISORS LLC | 11/14/2025 | 5.24 M | $11.62 M | -23.35% | 7.37% |
| MORGAN STANLEY | 11/14/2025 | 4.97 M | $11.04 M | 4.58% | 7.00% |
| WASATCH ADVISORS LP | 11/14/2025 | 4.85 M | $10.77 M | -34.64% | 6.83% |
| VANGUARD GROUP INC | 11/07/2025 | 3.19 M | $7.09 M | 5.75% | 4.49% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 2.05 M | $4.56 M | 2.25% | 2.89% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 1.93 M | $4.29 M | 75.62% | 2.72% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 11/12/2025 | 1.90 M | $4.21 M | 100.00% | 2.67% |
| BLACKROCK, INC. | 11/12/2025 | 1.60 M | $3.54 M | -12.74% | 2.25% |
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 11/14/2025 | 1.11 M | $2.47 M | 0.00% | 1.57% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 936.95 K | $2.08 M | -14.29% | 1.32% |
| TANG CAPITAL MANAGEMENT LLC | 11/14/2025 | 900.00 K | $2.00 M | 0.00% | 1.27% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 834.73 K | $1.85 M | 22.11% | 1.18% |
| TWO SIGMA ADVISERS, LP | 11/14/2025 | 763.10 K | $1.69 M | -5.95% | 1.07% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 725.30 K | $1.61 M | -2.65% | 1.02% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 515.44 K | $1.14 M | 265.41% | 0.73% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 11/17/2025 | 503.15 K | $1.12 M | 13.90% | 0.71% |
| CITADEL ADVISORS LLC | 11/14/2025 | 481.45 K | $1.07 M | 100.00% | 0.68% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 459.89 K | $1.02 M | -47.75% | 0.65% |
| SHAY CAPITAL LLC | 11/14/2025 | 420.00 K | $932.40 K | 100.00% | 0.59% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 350.61 K | $778.35 K | 5.64% | 0.49% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 349.29 K | $775.46 K | -19.13% | 0.49% |
| STATE STREET CORP | 11/14/2025 | 287.37 K | $637.97 K | 0.00% | 0.40% |
| SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 11/14/2025 | 272.05 K | $603.96 K | 114.38% | 0.38% |
| FMR LLC | 11/13/2025 | 211.35 K | $469.19 K | 4.96% | 0.30% |
| HENNION & WALSH ASSET MANAGEMENT, INC. | 10/22/2025 | 205.03 K | $455.17 K | -1.79% | 0.29% |
| ARROWMARK COLORADO HOLDINGS LLC | 11/14/2025 | 204.51 K | $454.00 K | 0.00% | 0.29% |
| JANE STREET GROUP, LLC | 11/14/2025 | 203.57 K | $451.92 K | -58.68% | 0.29% |
| LPL FINANCIAL LLC | 11/12/2025 | 200.93 K | $446.07 K | 2.38% | 0.28% |
| INVESCO LTD. | 11/13/2025 | 191.82 K | $425.84 K | 23.74% | 0.27% |
| ROYAL BANK OF CANADA | 11/14/2025 | 182.64 K | $405.00 K | -23.57% | 0.26% |
| XTX TOPCO LTD | 11/14/2025 | 149.96 K | $332.92 K | 38.50% | 0.21% |
| DIADEMA PARTNERS LP | 11/14/2025 | 140.70 K | $312.35 K | 100.00% | 0.20% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 11/14/2025 | 138.66 K | $307.82 K | -42.22% | 0.20% |
| NORTHERN TRUST CORP | 11/14/2025 | 138.32 K | $307.07 K | -0.97% | 0.19% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 131.40 K | $291.71 K | 100.00% | 0.19% |
| MARINER, LLC | 11/14/2025 | 128.24 K | $284.69 K | -3.41% | 0.18% |
| ACADIAN ASSET MANAGEMENT LLC | 11/13/2025 | 128.11 K | $282.00 K | -8.31% | 0.18% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2025 | 115.97 K | $257.46 K | 100.00% | 0.16% |
| ALGERT GLOBAL LLC | 11/14/2025 | 106.30 K | $236.00 K | 100.00% | 0.15% |
| MARSHALL WACE, LLP | 11/13/2025 | 106.28 K | $235.93 K | 100.00% | 0.15% |
| MAN GROUP PLC | 11/14/2025 | 90.28 K | $200.42 K | 15.02% | 0.13% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 90.00 K | $199.80 K | 100.00% | 0.13% |
| VIENNA POWSZECHNE TOWARZYSTWO EMERYTALNE S.A. VIENNA INSURANCE GROUP | 11/03/2025 | 85.00 K | $188.70 K | 0.00% | 0.12% |
| STATE OF WYOMING | 11/04/2025 | 82.51 K | $183.17 K | 100.00% | 0.12% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 80.81 K | $179.39 K | -60.81% | 0.11% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2025 | 79.90 K | $177.38 K | -23.83% | 0.11% |
| INTREPID FAMILY OFFICE LLC | 11/14/2025 | 70.00 K | $155.40 K | 75.00% | 0.10% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 11/14/2025 | 67.62 K | $150.11 K | 0.00% | 0.10% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
C4 Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 134 institutional investors and hedge funds held shares of C4 Therapeutics, Inc.. The most heavily invested institutionals were:
Lynx1 Capital Management LP: 7.1 M
Soleus Capital Management, L.P.: 7.05 M
ORBIMED ADVISORS LLC: 5.24 M
MORGAN STANLEY: 4.97 M
WASATCH ADVISORS LP: 4.85 M
VANGUARD GROUP INC: 3.19 M
73.99% of C4 Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 58.17 M shares in the last 24 months. This purchase volume represents approximately $132.05 M in transactions.